These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3814669)

  • 1. Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients.
    Szymanski HV; Naylor EW; Karoum F
    Biol Psychiatry; 1987 Feb; 22(2):194-8. PubMed ID: 3814669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of beta-phenylethylamine in plasma and plateletes of schizophrenics.
    Myojin T; Taga C; Tsuji M
    Jpn J Psychiatry Neurol; 1989 Jun; 43(2):171-6. PubMed ID: 2796027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylethylamine in paranoid chronic schizophrenia.
    Potkin SG; Karoum F; Chuang LW; Cannon-Spoor HE; Phillips I; Wyatt RJ
    Science; 1979 Oct; 206(4417):470-1. PubMed ID: 504988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma phenylethylamine in schizophrenic patients.
    O'Reilly R; Davis BA; Durden DA; Thorpe L; Machnee H; Boulton AA
    Biol Psychiatry; 1991 Jul; 30(2):145-50. PubMed ID: 1912106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia.
    Jeste DV; Doongaji DR; Panjwani D; Datta M; Potkin SG; Karoum F; Thatte S; Sheth AS; Apte JS; Wyatt RJ
    Psychiatry Res; 1981 Dec; 5(3):341-52. PubMed ID: 6948314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorometric assay for beta-phenylethylamine in human urine.
    Suzuki O; Yagi K
    Clin Chim Acta; 1977 Aug; 78(3):401-10. PubMed ID: 884865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [beta-Phenylethylamine in the cisternal fluid in acute endogenous psychoses].
    Uebelhack R; Franke L; Seidel K
    Biomed Biochim Acta; 1984; 43(11):1257-60. PubMed ID: 6532460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype.
    Ko GN; Jimerson DC; Wyatt RJ; Bigelow LB
    Arch Gen Psychiatry; 1988 Sep; 45(9):842-6. PubMed ID: 3415425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia.
    Potkin SG; Cannon-Spoor HE; DeLisi LE; Neckers LM; Wyatt RJ
    Arch Gen Psychiatry; 1983 Jul; 40(7):749-52. PubMed ID: 6860076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma phenylethylamine levels of schizophrenic patients.
    Shirkande S; O'Reilly R; Davis B; Durden D; Malcom D
    Can J Psychiatry; 1995 May; 40(4):221. PubMed ID: 7621397
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma beta-phenylethylamine in Parkinson's disease.
    Miura Y
    Kurume Med J; 2000; 47(4):267-72. PubMed ID: 11197147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls.
    Potkin SG; Wyatt RJ; Karoum F
    Psychopharmacol Bull; 1980 Jan; 16(1):52-4. PubMed ID: 7360842
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers.
    Davis BA; O'Reilly RL; Placatka CL; Paterson IA; Yu PH; Durden DA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):611-23. PubMed ID: 1956990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylethylamine in neuropsychiatric disorders.
    Wolf ME; Mosnaim AD
    Gen Pharmacol; 1983; 14(4):385-90. PubMed ID: 6352395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Excretion of 3,4-dimethoxy phenylethylamine in the urine of schizophrenics].
    Zimmermann K; Moschke P; Wieder KH
    Psychiatr Neurol Med Psychol (Leipz); 1976 Mar; 28(3):163-73. PubMed ID: 967948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.
    Sabelli HC; Fawcett J; Gusovsky F; Javaid JI; Wynn P; Edwards J; Jeffriess H; Kravitz H
    J Clin Psychiatry; 1986 Feb; 47(2):66-70. PubMed ID: 3944066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylethylaminergic mechanisms in attention-deficit disorder.
    Baker GB; Bornstein RA; Rouget AC; Ashton SE; van Muyden JC; Coutts RT
    Biol Psychiatry; 1991 Jan; 29(1):15-22. PubMed ID: 2001444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylacetic acid in CSF and serum in Indian schizophrenic patients.
    Davis BA; Shrikhande S; Paralikar VP; Hirsch SR; Durden DA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):41-7. PubMed ID: 2008539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.